Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stephen, Lindsey"'
Publikováno v:
In American Journal of Otolaryngology--Head and Neck Medicine and Surgery July-August 2024 45(4)
Autor:
Stacey S. Cofield, Shaila Kamal, Joseph Huffstutter, Norma Mendoza, Theresa L. Ford, S. Louis Bridges, Allen Jankeel, William Shergy, Jeffrey R. Curtis, David Ridley, Kaleb Michaud, John Bassler, Atul Deodhar, Alan Kivitz, Sarah A.R. Siegel, Stephen Lindsey, Kevin L. Winthrop, Ted R. Mikuls, Ilhem Messaoudi
Publikováno v:
Annals of Internal Medicine. 174:1510-1518
Background The safety and effectiveness of live virus vaccines, such as the varicella-zoster vaccine, are unknown in patients with inflammatory diseases receiving immunomodulatory therapy such as tumor necrosis factor inhibitors (TNFis). Objective To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffb757048defe3093afcf17096ad129
https://doi.org/10.7326/m20-6928
https://doi.org/10.7326/m20-6928
Autor:
Stephen Lindsey, Koshika Soma, Roy Fleischmann, Svitlana Tatulych, Leonard H. Calabrese, Sang-Heon Lee, Noriko Iikuni, Liza Takiya, Zhen Luo, Carlos Abud-Mendoza
Publikováno v:
Arthritis Care & Research
Objective To explore herpes zoster (HZ) rates and live zoster vaccine (LZV) safety in a subset of patients with rheumatoid arthritis who received LZV before tofacitinib ± methotrexate (MTX), or adalimumab (ADA) plus MTX in the ORAL Strategy. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e36bda4c8862c051625c825b8f1b7920
https://doi.org/10.1002/acr.24010
https://doi.org/10.1002/acr.24010
Autor:
Stephen Lindsey, Haiyun Fan, Connie Chen, Chudy I. Nduaka, Lisy Wang, Tomohiro Hirose, Kunihiro Yamaoka, Eustratios Bananis, Jeffrey R. Curtis, Hernan Valdez, Yoshiya Tanaka, Kevin L. Winthrop, Alan M. Mendelsohn
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib. The aim of this study was to evaluate whether concomitant treatment with convent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::608fe9843504bb91622bbfb134eb07cc
https://doi.org/10.1002/art.40189
https://doi.org/10.1002/art.40189
Autor:
Zhen Luo, L. Calabrese, Koshika Soma, Carlos Abud-Mendoza, Stephen Lindsey, Roy Fleischmann, Noriko Iikuni, S.-H. Lee, Liza Takiya
Publikováno v:
Saturday, 16 JUNE 2018.
Background: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Patients (pts) with RA are at increased risk for herpes zoster (HZ) and this risk is further increased with tofacitinib treatment.1 Objectives:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac425777300ba57a2964e62dd7ed69b1
https://doi.org/10.1136/annrheumdis-2018-eular.1469
https://doi.org/10.1136/annrheumdis-2018-eular.1469
Autor:
Stephen Lindsey, Eustratios Bananis, Kevin L. Winthrop, Haiyun Fan, Lisy Wang, D. Gelone, Jeffrey R. Curtis, Alan M. Mendelsohn
Publikováno v:
Annals of the Rheumatic Diseases. 74:741.2-741
Background Rheumatoid arthritis (RA) patients are at increased risk for herpes zoster (HZ), and treatment with tofacitinib, an oral janus kinase (JAK) inhibitor, appears to increase this risk. 1 Prior analysis from the RA development programme for to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6d213b59708b4121d18cbb91c52a96c
https://doi.org/10.1136/annrheumdis-2015-eular.4139
https://doi.org/10.1136/annrheumdis-2015-eular.4139
Publikováno v:
The Journal of the Acoustical Society of America. 136:2182-2182
The trend in corporate workplace has been away from closed plan gypsum board offices to open plan workstations and offices with glass fronts, sliding doors, and clearstories or glass fins in the wall between offices. These designs are often a kit of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::887e9d2eff312d5f870c036be31332ca
https://doi.org/10.1121/1.4899904
https://doi.org/10.1121/1.4899904